Meloxicam
37 NDCs across 12 manufacturers|37 Generic,0 Brand
Meloxicam is used to treat rheumatoid arthritis and osteoarthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 13, 2000, and the first generic was approved Jul 19, 2006. FDA's Orange Book lists 28 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $52 million on Meloxicam across 12.1 million claims for 4.1 million beneficiaries.
Meloxicam is available as 37 NDCs from 12 manufacturers (37 generic, 0 brand), with NADAC prices from $0.02 to $11.25 per EA — the most expensive product costs about 679× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
37
37G / 0B
Manufacturers
12
competing in market
Price Spread
$0.02 – $11.25
per EA
7d Activity
avg -0.7% WoW · of 37 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Cipla USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nonsteroidal Anti-inflammatory Drug class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
12 manufacturers producing MELOXICAM(2 pricing outliers)
Frequently Asked Questions
What is Meloxicam used to treat?
Meloxicam is used to treat rheumatoid arthritis and osteoarthritis, per the National Library of Medicine's MED-RT classification.
When did Meloxicam become available as a generic?
FDA approved the first generic Meloxicam (ANDA) on Jul 19, 2006. The Orange Book currently lists 28 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Meloxicam?
In 2024, Medicare Part D spent $52 million on Meloxicam across 12.1 million claims for 4.1 million beneficiaries.
How many Meloxicam products are on the market?
The Meloxicam drug market contains 37 NDCs from 12 manufacturers — 37 generic and 0 brand products.
What is the price range for Meloxicam?
NADAC reference prices for Meloxicam range from $0.0166 to $11.2463 per EA — the most expensive product costs about 679× the cheapest.
Which manufacturers make Meloxicam?
12 manufacturers list Meloxicam in NADAC. Ranked by number of NDCs, the largest are Cipla USA Inc. (6), Aurobindo Pharma Limited (4), Unichem Pharmaceuticals (USA) Inc. (4), Exelan Pharmaceuticals Inc. (4), Zydus Pharmaceuticals (USA) Inc. (4).
How has the price of Meloxicam changed recently?
Over the past 7 days, 18 Meloxicam NDCs rose and 17 fell, with a market-wide average change of -0.7%.